These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37658095)

  • 41. Alkaptonuria in Slovakia: thirty-two years of research on phenotype and genotype.
    Srsen S; Müller CR; Fregin A; Srsnova K
    Mol Genet Metab; 2002 Apr; 75(4):353-9. PubMed ID: 12051967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toward a generalized computational workflow for exploiting transient pockets as new targets for small molecule stabilizers: Application to the homogentisate 1,2-dioxygenase mutants at the base of rare disease Alkaptonuria.
    Bernini A; Galderisi S; Spiga O; Bernardini G; Niccolai N; Manetti F; Santucci A
    Comput Biol Chem; 2017 Oct; 70():133-141. PubMed ID: 28869836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of HGD Gene Mutations in Patients with Alkaptonuria from the United Kingdom: Identification of Novel Mutations.
    Usher JL; Ascher DB; Pires DE; Milan AM; Blundell TL; Ranganath LR
    JIMD Rep; 2015; 24():3-11. PubMed ID: 25681086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The molecular basis of alkaptonuria.
    Fernández-Cañón JM; Granadino B; Beltrán-Valero de Bernabé D; Renedo M; Fernández-Ruiz E; Peñalva MA; Rodríguez de Córdoba S
    Nat Genet; 1996 Sep; 14(1):19-24. PubMed ID: 8782815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical presentation of 13 children with alkaptonuria.
    Kujawa MJ; Świętoń D; Wierzba J; Grzywińska M; Budziło O; Limanówka M; Pierzynowska K; Gaffke L; Grabowski Ł; Cyske Z; Rintz E; Rąbalski Ł; Kosiński M; Węgrzyn G; Mański A; Anikiej-Wiczenbach P; Ranganath L; Piskunowicz M
    J Inherit Metab Dis; 2023 Sep; 46(5):916-930. PubMed ID: 37395296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation and polymorphism analysis of the human homogentisate 1, 2-dioxygenase gene in alkaptonuria patients.
    Beltrán-Valero de Bernabé D; Granadino B; Chiarelli I; Porfirio B; Mayatepek E; Aquaron R; Moore MM; Festen JJ; Sanmartí R; Peñalva MA; de Córdoba SR
    Am J Hum Genet; 1998 Apr; 62(4):776-84. PubMed ID: 9529363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative stress and mechanisms of ochronosis in alkaptonuria.
    Braconi D; Millucci L; Bernardini G; Santucci A
    Free Radic Biol Med; 2015 Nov; 88(Pt A):70-80. PubMed ID: 25733348
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alkaptonuria is a novel human secondary amyloidogenic disease.
    Millucci L; Spreafico A; Tinti L; Braconi D; Ghezzi L; Paccagnini E; Bernardini G; Amato L; Laschi M; Selvi E; Galeazzi M; Mannoni A; Benucci M; Lupetti P; Chellini F; Orlandini M; Santucci A
    Biochim Biophys Acta; 2012 Nov; 1822(11):1682-91. PubMed ID: 22850426
    [TBL] [Abstract][Full Text] [Related]  

  • 49. aku, a mutation of the mouse homologous to human alkaptonuria, maps to chromosome 16.
    Montagutelli X; Lalouette A; Coudé M; Kamoun P; Forest M; Guénet JL
    Genomics; 1994 Jan; 19(1):9-11. PubMed ID: 8188247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel mutations in the homogentisate 1,2 dioxygenase gene identified in Jordanian patients with alkaptonuria.
    Al-sbou M
    Rheumatol Int; 2012 Jun; 32(6):1741-6. PubMed ID: 21437689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel missense HGD gene mutation, K57N, in a patient with alkaptonuria.
    Grasko JM; Hooper AJ; Brown JW; McKnight CJ; Burnett JR
    Clin Chim Acta; 2009 May; 403(1-2):254-6. PubMed ID: 19306858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HGDiscovery: An online tool providing functional and phenotypic information on novel variants of homogentisate 1,2- dioxigenase.
    Karmakar M; Cicaloni V; Rodrigues CHM; Spiga O; Santucci A; Ascher DB
    Curr Res Struct Biol; 2022; 4():271-277. PubMed ID: 36118553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of tyrosine pathway enzymes in mice demonstrates that homogentisate 1,2-dioxygenase deficiency in the liver is responsible for homogentisic acid-derived ochronotic pigmentation.
    Wilson PJM; Ranganath LR; Bou-Gharios G; Gallagher JA; Hughes JH
    JIMD Rep; 2021 Mar; 58(1):52-60. PubMed ID: 33728247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening and molecular characterization of lethal mutations of human homogentisate 1, 2 dioxigenase.
    Sen Gupta PS; Islam RNU; Banerjee S; Nayek A; Rana MK; Bandyopadhyay AK
    J Biomol Struct Dyn; 2021 Mar; 39(5):1661-1671. PubMed ID: 32107984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
    Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
    J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of nitisinone in patients with alkaptonuria.
    Suwannarat P; O'Brien K; Perry MB; Sebring N; Bernardini I; Kaiser-Kupfer MI; Rubin BI; Tsilou E; Gerber LH; Gahl WA
    Metabolism; 2005 Jun; 54(6):719-28. PubMed ID: 15931605
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins.
    Braconi D; Millucci L; Bernini A; Spiga O; Lupetti P; Marzocchi B; Niccolai N; Bernardini G; Santucci A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):135-146. PubMed ID: 27865997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presentation of 14 alkaptonuria patients from Turkey.
    Akbaba AI; Ozgül RK; Dursun A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):289-294. PubMed ID: 31927521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical and molecular confirmation of alkaptonuria in a Sumatran orangutan (Pongo abelii).
    Fayette MA; Booth KTA; Lynnes TC; Luna C; Minich DJ; Wilson TE; Miller MJ
    Mol Genet Metab; 2023 Jul; 139(3):107628. PubMed ID: 37354891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment.
    Ranganath LR; Milan AM; Hughes AT; Dutton JJ; Fitzgerald R; Briggs MC; Bygott H; Psarelli EE; Cox TF; Gallagher JA; Jarvis JC; van Kan C; Hall AK; Laan D; Olsson B; Szamosi J; Rudebeck M; Kullenberg T; Cronlund A; Svensson L; Junestrand C; Ayoob H; Timmis OG; Sireau N; Le Quan Sang KH; Genovese F; Braconi D; Santucci A; Nemethova M; Zatkova A; McCaffrey J; Christensen P; Ross G; Imrich R; Rovensky J
    Ann Rheum Dis; 2016 Feb; 75(2):362-7. PubMed ID: 25475116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.